EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Guggulsterone, a Classical Lipid‐Lowering Phytosteroidal FXR Antagonist, as a Modulator of Lipid Signaling and Metabolic Reprogramming in Cancer

Nila Ganamurali iD, Mohanapriya Devarajan, Sarvesh Sabarathinam iD

Lipids · 2026-05 · 61 (3) · 279-284

DOI: 10.1002/lipd.70030 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Lipids, online erschienen am 01.12.2025. Verfasst von Nila Ganamurali und 2 weiteren Autor:innen. Beteiligte Einrichtung: Helix Research Lab, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chenna…. Hauptthemen laut MEDLINE: Pregnenediones, Receptors, Cytoplasmic and Nuclear, Lipid Metabolism, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulated lipid metabolism fuels cancer progression through enhanced lipogenesis, cholesterol synthesis, and fatty acid oxidation. Herbal bioactives provide multi‐targeted molecular interventions capable of restoring lipid homeostasis while minimizing toxicity. Guggulsterone (GS), a plant‐derived steroidal compound from Commiphora mukul , exemplifies this paradigm by modulating key regulators such as ATP citrate lyase (ACLY), acetyl‐CoA carboxylase (ACC), farnesoid X receptor (FXR), and AMP‐activated protein kinase (AMPK). Through these actions, it suppresses oncogenic lipid signaling, reprograms the tumor microenvironment, and enhances apoptotic sensitivity. This article outlines the molecular underpinnings of GS's lipid‐lowering and antitumor effects, emphasizing its potential as a pharmacological scaffold for metabolic reprogramming in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PregnenedionesReceptors, Cytoplasmic and NuclearLipid MetabolismNeoplasmsHumansSignal TransductionAnimalsMetabolic Reprogramming

Stichwörter der Autor:innen

AMPK‐FXR signalingguggulsteroneherbal bioactiveslipid metabolism reprogrammingtumor microenvironment

Substanzen

pregna-4,17-diene-3,16-dionePregnenedionesReceptors, Cytoplasmic and Nuclear

Autor:innen und Institutionen

  • Helix Research Lab, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India.
  • Department of Gynaecologic Oncology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India.

ORCID-Profile: Nila Ganamurali, Sarvesh Sabarathinam

Zitieren

APA

Ganamurali, N., Devarajan, M., & Sabarathinam, S. (2026). Guggulsterone, a Classical Lipid‐Lowering Phytosteroidal FXR Antagonist, as a Modulator of Lipid Signaling and Metabolic Reprogramming in Cancer. Lipids, 61(3), 279-284. https://doi.org/10.1002/lipd.70030

Vancouver

Ganamurali N, Devarajan M, Sabarathinam S. Guggulsterone, a Classical Lipid‐Lowering Phytosteroidal FXR Antagonist, as a Modulator of Lipid Signaling and Metabolic Reprogramming in Cancer. Lipids. 2026;61(3):279-284. doi:10.1002/lipd.70030

BibTeX
@article{Ganamurali2026,
  author = {Ganamurali, Nila and Devarajan, Mohanapriya and Sabarathinam, Sarvesh},
  title = {Guggulsterone, a Classical Lipid‐Lowering Phytosteroidal FXR Antagonist, as a Modulator of Lipid Signaling and Metabolic Reprogramming in Cancer},
  journal = {Lipids},
  year = {2026},
  volume = {61},
  number = {3},
  pages = {279--284},
  doi = {10.1002/lipd.70030}
}
Kostenlos starten →